Cummings Keith Lamont (CIK 1809204) reported 3 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-01-22). Recent activity: Sell PLRX (24,002 shares), Buy PLRX (56,650 shares), Sell PLRX (20,148 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-01-22 | PLIANT THERAPEUTICS, INC. (PLRX) | Chief Financial Officer | Sell | 24,002 | $30,723 |
| 2025-01-27 | PLIANT THERAPEUTICS, INC. (PLRX) | Chief Financial Officer | Buy | 56,650 | $0 |
| 2025-01-22 | PLIANT THERAPEUTICS, INC. (PLRX) | Chief Financial Officer | Sell | 20,148 | $225,658 |
Source: SEC Form 4 filings · as of 2026-01-22